AI based microcalcification detection and classification on mammography may help diagnose breast cancer early
A team led by Lin et al. developed a deep-learning mammography system. This system is trained to identify microcalcification and focuses on interpreting it. Based on the study's findings, a critical perspective is highlighted that using Automated artificial intelligence (AI) systems may assist clinicians in making judgments and improve their efficiency in breast cancer screening, diagnosis, and treatment.
The study Artificial Intelligence-based Diagnosis of breast cancer by mammography microcalcification is published in Fundamental Research.
AI's ability to predict pathological types and ER needs more exploration. Mammography is used for screening of breast cancer screening. Detecting microcalcifications associated with malignancy is vital in diagnosing breast cancer early. Computer-aided diagnosis (CAD) is a promising efficient and accurate technique. In this study, researchers demonstrated an automated deep-learning pipeline for microcalcification detection and classification in mammography.
The team explained, "We built an AI system using deep-learning methods. This includes standardization of images, detection of microcalcification and classification of mammography. Based on Faster RCNN, the model automatically searches for calcification regions in mammography determining benign and malignancy."
FPN structure was used to fuse deep features at different scales as there are small microcalcifications. Considering detection boxes and prediction results presented by the detection model, we determined the category of mammography images (benign or malignant), such as the presence of a malignant box in mammography interpreted as malignant.
The key results of this study are:
- The detection model accurately extracted calcification regions.
- Researchers used a large mammography dataset.
- There were 4,810 mammograms and 6,663 microcalcification lesions.
- The malignant and benign lesions were 3,301 and 3,362, respectively.
- For training and test set, classification accuracy values for discriminating between benign and malignant breasts were 0.8124 and 0.7237, respectively.
- The sensitivity values of malignant breast cancer prediction were 0.8891 and 0.7778, respectively.
- The overall accuracy for the mammograph image level was 0.7055, with an AUC of 0.7753, and 0.7511 for the microcalcification lesion level, with an AUC of 0.7627.
To validate the effectiveness of our deep-learning model, we visualized the feature extraction backbone of our detection network, they said.
They said, "We explored the ability of AI to distinguish between invasive and noninvasive breast cancers and also used it to determine the molecular subtypes of breast carcinoma."
A trained deep-learning model identifying only microcalcification lesions for diagnosing breast cancer early can achieve better accuracy.
We could provide the classification results of mammography images and annotate specific calcification regions. They said this is a rare finding in the literature, and further investigations are warranted in this context.
Further reading:
https://www.sciencedirect.com/science/article/pii/S2667325823001814?via=ihub
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.